Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

Massachusetts General Brigham (MGB) Chief Innovation Officer Christopher Coburn had overseen a period of exciting transformation and growth in healthcare innovation at MGB. In November 2019, the health system was the largest recipient of National Institutes of Health (NIH) funding in the world. The Innovation Office sought to capitalize on that funding. Their team aimed to help the organization's 3,505 Principal Investigators translate and commercialize their research, with the goal of both producing revenue and improving patient care. Despite the success of Coburn and the Innovation Office over the last decade, MGB CEO Anne Klibanski and other key stakeholders had a serious concern. Although women comprised approximately 40% of the medical researchers and physicians it employed, the percentage of women participating in innovation activities lagged behind - in some categories, by a ratio of 4:1. Coburn knew that change would require an understanding of the main sources of disparities, the right strategy to address those disparities, and an equally robust execution. How could MGB expand and diversify its community of innovators?
Industry:
Size:
> 1 billion; Large
Other setting(s):
2019

About

Abstract

Massachusetts General Brigham (MGB) Chief Innovation Officer Christopher Coburn had overseen a period of exciting transformation and growth in healthcare innovation at MGB. In November 2019, the health system was the largest recipient of National Institutes of Health (NIH) funding in the world. The Innovation Office sought to capitalize on that funding. Their team aimed to help the organization's 3,505 Principal Investigators translate and commercialize their research, with the goal of both producing revenue and improving patient care. Despite the success of Coburn and the Innovation Office over the last decade, MGB CEO Anne Klibanski and other key stakeholders had a serious concern. Although women comprised approximately 40% of the medical researchers and physicians it employed, the percentage of women participating in innovation activities lagged behind - in some categories, by a ratio of 4:1. Coburn knew that change would require an understanding of the main sources of disparities, the right strategy to address those disparities, and an equally robust execution. How could MGB expand and diversify its community of innovators?

Settings

Industry:
Size:
> 1 billion; Large
Other setting(s):
2019

Related